Akums Patents Formulation for Sickle Cell Disease Management
By Rediff Money Desk, New Delhi Sep 13, 2024 17:22
Akums Drugs and Pharmaceuticals secures patent for a room temperature stable oral suspension of Hydroxyurea, a cost-effective treatment for Sickle Cell Disease (SCD) in India and worldwide.
New Delhi, Sep 13 (PTI) Akums Drugs and Pharmaceuticals on Friday said it has received patent for a formulation for Sickle Cell Disease (SCD).
The company has received a patent from India patent office for its room temperature stable oral suspension of Hydroxyurea, a formulation aimed at managing SCD.
"Our constant endeavor is to work on affordable medicines for Orphan Drugs and reduce dependency on imported medicines ensuring patient safety from rare diseases with timely and necessary treatment," Akums Managing Director Sanjeev Jain said in a statement.
SCD, a genetic blood disorder, leads to severe health complications such as anaemia, frequent pain episodes and other debilitating symptoms, affecting millions worldwide, especially in India and Africa.
Akums said its formulation will come at a fraction of the cost of imported Hydroxyurea solution.
The company has received a patent from India patent office for its room temperature stable oral suspension of Hydroxyurea, a formulation aimed at managing SCD.
"Our constant endeavor is to work on affordable medicines for Orphan Drugs and reduce dependency on imported medicines ensuring patient safety from rare diseases with timely and necessary treatment," Akums Managing Director Sanjeev Jain said in a statement.
SCD, a genetic blood disorder, leads to severe health complications such as anaemia, frequent pain episodes and other debilitating symptoms, affecting millions worldwide, especially in India and Africa.
Akums said its formulation will come at a fraction of the cost of imported Hydroxyurea solution.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Rhetan TMT
- 15.59 (+ 19.83)
- 31433475
- Srestha Finvest
- 1.79 ( -1.10)
- 29026799
- Spicejet Ltd.
- 71.66 (+ 8.00)
- 28325118
- Rama Steel Tubes
- 16.26 (+ 1.82)
- 21693933
- Vodafone Idea L
- 13.41 ( -0.89)
- 19325317
MORE NEWS
SEBI Drops Charges Against NSE, Employees in...
SEBI dismissed regulatory charges against the NSE and its former employees in the...
Efficient Logistics & Paperless Systems Boost...
Commerce Secretary Sunil Barthwal highlights the importance of efficient logistics and...
Food Procurement System Improvement: FCI &...
The Department of Food and Public Distribution and FCI signed an MoU to enhance...